L’Oréal USA S/D Inc faces a proposed consumer class action alleging that two CeraVe products marketed for babies are materially identical to their standard counterparts but sold at higher prices.
Monica Raymundo filed Raymundo v L’Oréal USA S/D Inc on 9 July 2026 in the US District Court for the Southern District of California. The case, numbered 3:26-cv-03951-RBM-DEB, is assigned to US District Judge Ruth Bermudez Montenegro and Magistrate Judge Daniel E. Butcher.
The complaint concerns CeraVe Baby Healing Ointment and CeraVe Baby Eczema Cream. Raymundo alleges that their active ingredients, inactive ingredients and directions match those of CeraVe Healing Ointment and CeraVe Eczema Moisturizing Cream, despite baby-focused labelling and marketing references to pediatric dermatologists and babies’ sensitive skin.
Both healing ointments contain 46.5% petrolatum, while both eczema creams contain 1% colloidal oatmeal, according to the filing. The complaint says the inactive ingredients appear in the same order and that the directions for the baby and standard products are identical. The allegations have not been decided by the court.
Raymundo says she bought CeraVe Baby Healing Ointment from Amazon in June 2024 after relying on the baby labelling. She seeks to represent California purchasers who bought either product for personal or household use from four years before the complaint was filed through the date the class is notified. The complaint invokes the Class Action Fairness Act and states that the amount in controversy exceeds $5 million, excluding interest and costs.
Pricing cited in the filing includes CeraVe.com, Target, Walmart, Amazon, CVS and Dermstore. The complaint alleges that the baby eczema cream cost more per ounce and that the three-ounce baby healing ointment carried a premium of 30% or more at some retailers. Those comparisons remain allegations rather than findings.
Fitzgerald Monroe Flynn PC represents Raymundo. The complaint names Jack Fitzgerald, Melanie R. Monroe, Trevor Flynn, Kaden Byron, Allison Ferraro and Daniel E. Sachs as counsel. It pleads claims under California’s Unfair Competition Law, False Advertising Law and Consumers Legal Remedies Act, together with negligent misrepresentation and unjust enrichment.
The dispute places product-development records, label approval and pricing evidence at the centre of the case. Solicitors and in-house counsel advising consumer brands will need to test whether marketing language implies a formulation difference that technical records can support.
Defence lawyers are likely to challenge reliance, standing, classwide loss and the claim for injunctive relief. Claimant firms will need to show that the alleged price premium can be measured consistently across the proposed class.
L’Oréal’s response should indicate whether it disputes the product comparison, the way consumers understood the labels or the legal basis of the claims. Lawyers advising manufacturers and retailers should check that product descriptions, ingredient lists and pricing records support any distinction made between standard and specialist versions.